Egetis Therapeutics AB (publ)
556706-6724ActiveInnovative pharmaceutical company developing late-stage orphan drug treatments.
Oversigt
- 20–49
- Medarbejdere
- 100–500mio SEK
- Omsætning
- 2006
- Grundlagt
Nøglebeslutningstagere
Yilmaz Mahshid
Chief Financial Officer
Karl Hård
Vice President, Head of Investor Relations and Business Development
Nicklas Westerholm
Chief Executive Officer
Anny Bedard
President Egetis North America
+16 flere kontakter i Funnelfeedr
Beskrivelse
Egetis Therapeutics is an innovative and integrated pharmaceutical company focused on bringing novel treatments to market. The organization concentrates its efforts on projects in late-stage development, aiming for commercialization of specialized therapies. Their primary focus lies within the orpha...
Tags
Nøgleord
Teknologistak
Virksomhedsoplysninger
- Branche
- Annan naturvetenskaplig och teknisk forskning och utveckling
- Juridisk form
- Aktiebolag
- Momsnummer
- SE556706672401
Beslutningstagere
20 kontakter i FunnelfeedrYilmaz Mahshid
Chief Financial Officer
Karl Hård
Vice President, Head of Investor Relations and Business Development
Nicklas Westerholm
Chief Executive Officer
Anny Bedard
President Egetis North America
Christian Sonesson
Vice President Product Strategy & Development
Gunilla Osswald
Board Member
Tiago Nunes
Chief Medical Officer
Laetitia Szaller
General Counsel & Head of Compliance
Nils Hallén
Global Head of HR
Elisabeth Svanberg
Board Member
Margarida Duarte
Board Member
Sofie Broberg
Vice President Regulatory Affairs
Katayoun Welin-Berger
Vice President Technical Operations
Birgitte Volck
Board Member
Henrik Krook
Vice President Commercial Operations
Mats Blom
Chairman of the Board
Behshad Sheldon
Board Member
Katayoun (Katy) Welin-Berger
Vice President Operations
Jay Donovan Wu
Board Member
Kristina Sjöblom Nygren
Chief Medical Officer
Lignende virksomheder
20 lignende virksomheder i FunnelfeedrPTC Therapeutics Sweden AB
Developing transformative treatments for rare diseases globally for patients.
AMICUS THERAPEUTICS LTD
1–4 medarbejdereGlobal biotechnology company developing transformative medicines for rare diseases.
Swedish Orphan Biovitrum AB (publ)
200–499 medarbejdereGlobal biopharma unlocking breakthrough therapies for rare diseases.
Alnylam Sweden AB
5–9 medarbejdereLeading RNAi therapeutics company developing gene-silencing medicines.
NORGINE HEALTHCARE B.V.
0 medarbejdereLeading European specialist pharmaceutical company acquiring and commercializing medicines.
Udforsk mere
Spørgsmål om Egetis Therapeutics AB (publ)
Vil du se Funnelfeedr i aktion?
Book en gratis demo og opdag, hvordan Funnelfeedr hjælper dig med at finde og konvertere dine ideelle kunder.
Book en demo